May 24 (Reuters) - Novo Nordisk A/S NOVOb.CO :
* PEOPLE TREATED WITH SAXENDA (LIRAGLUTIDE 3 MG) FOR WEIGHT MANAGEMENT LOST AN AVERAGE OF 8.1 KG AFTER SIX MONTHS IN A REAL-WORLD CLINICAL SETTING, IN COMBINATION WITH DIET AND EXERCISE
* THE RETROSPECTIVE EFFECTIVENESS STUDY INVESTIGATED THE IMPACT OF SAXENDA TREATMENT IN PEOPLE WITH OVERWEIGHT AND OBESITY ACROSS SIX WEIGHT MANAGEMENT CLINICS IN CANADA
* AFTER SIX MONTHS, PEOPLE TREATED WITH SAXENDA AS AN ADJUNCT TO DIET AND EXERCISE ACHIEVED 7.1% WEIGHT LOSS FROM BASELINE, WITH 63.4% AND 35.2% OF PEOPLE LOSING ≥5%
AND >10% OF THEIR BODY WEIGHT, RESPECTIVELY
* RESULTS FROM THE REAL-WORLD STUDY WERE IN LINE WITH THOSE OBSERVED IN THE SCALE CLINICAL TRIAL PROGRAMME